Chemed
CHE
Market cap $8.06B

551.15 USD

-6.87

1.23%

At close Jun 13, 4:00 PM EDT

1 day

-1.23%

5 days

-1.60%

1 month

-1.08%

3 months

-6.58%

6 months

0.76%

Year to date

4.39%

1 year

2.36%

5 years

24.13%

10 years

330.86%

About: Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Employees: 15,695

Healthcare Medical Care Facilities

0

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

150% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 5 (+3) [Q1 2025]

59% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 54

57% more call options, than puts

Call options by funds: $8.12M | Put options by funds: $5.16M

13% more capital invested

Capital invested by funds: $7.35B [Q4 2024] → $8.34B (+$988M) [Q1 2025]

4% more funds holding

Funds holding: 527 [Q4 2024] → 547 (+20) [Q1 2025]

0.03% less ownership

Funds ownership: 92.67% [Q4 2024] → 92.64% (-0.03%) [Q1 2025]

8% less repeat investments, than reductions

Existing positions increased: 181 | Existing positions reduced: 196

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$674

22%

upside

Avg. target

$674

22%

upside

High target

$674

22%

upside

1 analyst rating

1 positive

100%

0 neutral

0%

0 negative

0%

RBC Capital

Ben Hendrix

22%upside

$674

Outperform

Maintained

28 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about CHE published over the past 30 days

Zacks Investment Research

AMED or CHE: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?

AMED or CHE: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock?

Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cas.

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. L.

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

Chemtrade Logistics Income Fund (CGIFF) Q1 2025 Earnings Call Transcript

Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Rohit Bhardwaj – Chief Financial Officer Scott Rook – President and Chief Executive Officer Conference Call Participants Joel Jackson – BMO Capital Markets Gary Ho – Desjardins Capital Markets Nelson Ng – RBC Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund First Quarter 2025 Conference Call. I would now like to turn the conference call over to Rohit Bhardwaj, Chief Financial Officer.

Chemtrade Logistics Income Fund (CGIFF) Q1 2025 Earnings Call Transcript

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and.

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

Zacks Investment Research

OPCH vs. CHE: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?

OPCH vs. CHE: Which Stock Is the Better Value Option?

Zacks Investment Research

CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines

Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.

CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines

Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript

Chemed Corporation (NYSE:CHE ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and CEO Mike Witzeman - CFO Nick Westfall - Chairman and CEO, Chemed VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Chemed Corporation First Quarter 2025 Earnings Conference Call.

Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript

Zacks Investment Research

Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates

Chemed (CHE) came out with quarterly earnings of $5.63 per share, beating the Zacks Consensus Estimate of $5.60 per share. This compares to earnings of $5.20 per share a year ago.

Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates

See News Rankings

Charts implemented using Lightweight Charts™